Ashley Bruckenthal, | |
30 Deepwood Dr, Bethel, CT 06801-1267 | |
(203) 927-8907 | |
Not Available |
Full Name | Ashley Bruckenthal |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 30 Deepwood Dr, Bethel, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295281178 | NPI | - | NPPES |
1336163963 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | P03381 (New York) | Secondary |
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ashley Bruckenthal, 54 Danbury Rd Ste 337, Ridgefield, CT 06877-4019 Ph: () - | Ashley Bruckenthal, 30 Deepwood Dr, Bethel, CT 06801-1267 Ph: (203) 927-8907 |
News Archive
Cerapedics, Inc., a medical device company focused on developing and commercializing novel osteobiologic products, announced the results of a prospective, randomized, controlled trial of its i-FACTOR biologic bone graft for patients undergoing posterior lumbar interbody fusion spine procedures.
Using data from its unique online research platform, 23andMe, a leading personal genetics company, has identified seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three SNPs also correlated with breast cancer in a genome-wide association study (GWAS) now published online in BMC Medical Genetics.
UC San Francisco researchers have successfully isolated human muscle stem cells and shown that the cells could robustly replicate and repair damaged muscles when grafted onto an injured site. The laboratory finding paves the way for potential treatments for patients with severe muscle injury, paralysis or genetic diseases such as muscular dystrophy.
As a nationally recognized healthcare organization, home to one of the most advanced vascular interventional practices in the country, Terrebonne General Medical Center (TGMC) handles approximately 3,300 cath lab patients annually. Patients from all over the country come to TGMC for interventional treatment for conditions associated with cardiovascular disease (CVD) and peripheral vascular disease (PVD), including limb ischemia.
The best available treatment for chronic kidney disease from high blood pressure did not keep the disease from substantially worsening in about a fourth of African-Americans studied, according to long-term results of a National Institutes of Health study published April 28, 2008, in the Archives of Internal Medicine.
› Verified 8 days ago